Small Molecule PET Tracers in Drug Discovery.

Area of Science:

• Pharmacology
• Molecular Imaging
• Drug Development

Background:

• Pharmaceutical development is resource-intensive, lengthy, and high-risk.
• Molecular imaging, particularly PET, offers valuable decision-making tools.
• PET provides quantitative, molecular-level insights into drug candidates and targets.

Purpose of the Study:

• To review the application of small molecule PET tracers in drug discovery.
• To highlight PET's role in optimizing drug candidate selection.
• To demonstrate how PET accelerates pharmaceutical development.

Main Methods:

• Focus on small molecule PET tracers.
• Application of PET in preclinical and clinical studies.
• Utilizing PET for pharmacokinetic and pharmacodynamic assessments.

Main Results:

• PET enables informed decisions on drug candidates, targets, doses, and patient populations.
• PET provides crucial pharmacokinetic and pharmacodynamic data.
• PET is integrated across all drug discovery and development phases.

Conclusions:

• PET imaging is a powerful tool for enhancing drug discovery efficiency.
• PET contributes to de-risking the pharmaceutical development pipeline.
• The use of PET aims to accelerate the delivery of new medicines.